Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1711)
  2. Journal Article (1446)
  3. Review (84)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (11)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3406)
  2. Solid Tumor Oncology Division (3406)
  3. GSK Faculty (1075)
  4. Department of Pathology and Laboratory Medicine (821)
  5. Hematology-Oncology Fellows (715)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (664)

More Groups

People
  1. Mark Kris (873)
  2. Alexander Drilon (639)
  3. Gregory Riely (606)
  4. Charles Rudin (497)
  5. Marc Ladanyi (419)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (126)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (704)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (159)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (90)

More Publications

Publishers
  1. American Society of Clinical Oncology (783)
  2. Elsevier Inc. (741)
  3. American Association for Cancer Research (387)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (80)

More Publishers

Results (3406)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multi-modality AI predictor of lung cancer immunotherapy treatment response of durable response (DR)
    Meeting Abstract

    Jiang, J.; Yu, H.; Gomez, D.; Veeraraghavan, H.
    Radiotherapy and Oncology (2025)

    Fulltext@MSK | Save
  • A phase I study of AFNT-211, autologous CD4(+) and CD8(+) T cells engineered to express a high avidity HLA-A(*)11:01-restricted, KRAS G12V-specific transgenic TCR; CD8α/β coreceptor; and FAS-41BB switch receptor in patients with advanced or metastatic solid tumors
    Meeting Abstract

    Basu, S. K.; Khan, B.; Payumo, F.; Wan, R.; Chiorean, E. G.; Gahvari, Z.; Hecht, J. R.; Hurwitz, M. E.; Leidner, R. S.; Lenz, H. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Neoadjuvant osimertinib for resectable EGFR-mutated non-small cell lung cancer
    Journal Article

    He, J.; Tsuboi, M.; Weder, W.; Chen, K. N.; Hochmair, M. J.; Shih, J. Y.; Lee, S. Y.; Lee, K. Y.; Nhung, N. V.; Saeteng, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Overall survival in EGFR-mutant advanced NSCLC treated with first-line osimertinib: A cohort study integrating clinical and biomarker data in the United States
    Journal Article

    Sabari, J. K.; Yu, H. A.; Mahadevia, P. J.; Liu, Y.; Demirdjian, L.; Chen, Y. H.; Wang, X.; Passaro, A.
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Activating mutations in the MET kinase domain co-occur with other driver oncogenes and mediate resistance to targeted therapy in NSCLC
    Journal Article

    Nakazawa, S.; Pecci, F.; Ricciuti, B.; Gottlieb, F. H.; Facchinetti, F.; Harada, G.; Chen, M. F.; Repetto, M.; Giacomini, F.; Jiang, J.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Neoadjuvant PD-1 and PD-L1 blockade with chemotherapy for borderline resectable and unresectable Stage III non-small cell lung cancer
    Journal Article

    Ricciuti, B.; Fusco, F.; Cooper, A.; Garbo, E.; Pecci, F.; Aldea, M.; Wang, X.; Mayoral Penalva, M.; Ginsberg, M.; Sholl, L. M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Zipalertinib in patients with epidermal growth factor receptor exon 20 insertion-positive non-small cell lung cancer previously treated with platinum-based chemotherapy with or without amivantamab
    Journal Article

    Piotrowska, Z.; Passaro, A.; Nguyen, D.; Ruiter, G.; Soo, R. A.; Lee, V. H. F.; Velcheti, V.; Tan, D. S. W.; Lee, S. H.; Kim, S. H.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Entering a new era of tumor-infiltrating lymphocyte cell therapy innovation
    Review

    Amaria, R. N.; Komanduri, K. V.; Schoenfeld, A. J.; Ramsingh, G.; Burga, R. A.; Jagasia, M. H.
    Cytotherapy (2025)

    Fulltext@MSK | Save
  • Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection
    Journal Article

    Campanella, G.; Kumar, N.; Nanda, S.; Singi, S.; Fluder, E.; Kwan, R.; Muehlstedt, S.; Pfarr, N.; Schüffler, P. J.; Häggström, I.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Updated efficacy and safety from the phase 2 PHAROS study of encorafenib plus binimetinib in patients with BRAF V600E-mutant metastatic NSCLC—A brief report
    Journal Article

    Riely, G. J.; Ahn, M. J.; Clarke, J. M.; Dagogo-Jack, I.; Esper, R.; Felip, E.; Gelsomino, F.; Goldman, J. W.; Hussein, M.; Johnson, M.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save